Conquering Diseases

Study Of An Investigational Drug Combination For Advanced Breast Cancer

Description

Seeking men and women with hormone receptor positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced inoperable or metastatic breast cancer for a study of an investigational drug combination.

Overview

Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine). All participants will receive the standard chemotherapy for their type of breast cancer.

What we're hoping for

We are studying adding a investigational drug to chemotherapy for metastatic or advanced hormone receptor positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced inoperable or metastatic breast cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT04895358

 Principal Investigator

Madhavi  Toke, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989